VTYX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 49.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $36,781,042.82

Ventyx Biosciences Insider Trading History Chart

Ventyx Biosciences Share Price & Price History

^$37.75

▼ -1.91 (-4.82%)

As of 03/22/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Ventyx Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/23/2023	William Richard White	Director	Sell	33,353	$35.10	$1,170,690.30
12/22/2022	John Nuss	Insider	Sell	13,812	$31.61	$436,597.32	244,815
12/22/2022	Raju Mohan	CEO	Sell	55,354	$31.61	$1,749,739.94	1,603,126
12/16/2022	Somu Subramaniam	Director	Sell	146,825	$32.94	$4,836,415.50	12,974,786
12/15/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	153,175	$33.61	$5,148,211.75	13,121,611
12/13/2022	Christopher W Krueger	Insider	Sell	30,000	$34.46	$1,033,800.00	272,692
12/5/2022	John Nuss	Insider	Sell	50,000	$28.23	$1,411,500.00	258,696
12/5/2022	Raju Mohan	CEO	Sell	23,003	$28.44	$654,205.32	1,541,811
12/2/2022	Christopher W Krueger	Insider	Sell	50,000	$29.01	$1,450,500.00	302,692
12/2/2022	Martin Auster	CFO	Sell	97,647	$29.01	$2,832,739.47	47,649
12/2/2022	Raju Mohan	CEO	Sell	276,997	$29.01	$8,035,682.97	1,564,814
12/1/2022	Somu Subramaniam	Director	Sell	129,317	$29.01	$3,751,486.17	16,616,048
11/30/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	143,228	$29.01	$4,155,044.28	16,745,365
11/7/2022	Somu Subramaniam	Director	Sell	3,935	$29.08	$114,429.80	16,888,593
10/25/2021	Global Strategic Fund I Venbio	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00

The 1 Stock To Watch In This Market.

From Upexi, Inc | Ad

This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over!

SEC Filings (Institutional Ownership Changes) for Ventyx Biosciences (NASDAQ:VTYX)

95.57% of Ventyx Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ventyx Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2023	Voya Investment Management LLC	9,349	$0.31M	0.0%	+6.4%	0.017%
2/16/2023	Alliancebernstein L.P.	26,600	$0.87M	0.0%	+75.0%	0.047%
2/15/2023	State of Wisconsin Investment Board	17,015	$0.56M	0.0%	N/A	0.030%
2/15/2023	Soleus Capital Management L.P.	69,000	$2.26M	0.3%	N/A	0.122%
2/15/2023	Squarepoint Ops LLC	61,967	$2.03M	0.0%	N/A	0.109%
2/15/2023	Legal & General Group Plc	7,382	$0.24M	0.0%	+174.1%	0.013%
2/15/2023	Millennium Management LLC	108,703	$3.56M	0.0%	+435.6%	0.192%
2/15/2023	Morgan Stanley	119,214	$3.91M	0.0%	+44.0%	0.210%
2/15/2023	EAM Global Investors LLC	46,189	$1.52M	0.4%	-36.0%	0.082%
2/15/2023	EAM Investors LLC	64,927	$2.13M	0.4%	-22.0%	0.115%
2/15/2023	Fred Alger Management LLC	28,290	$0.93M	0.0%	+138.2%	0.050%
2/15/2023	Alps Advisors Inc.	38,391	$1.26M	0.0%	N/A	0.068%
2/15/2023	Avidity Partners Management LP	1,285,000	$42.14M	0.9%	N/A	2.269%
2/15/2023	venBio Partners LLC	3,461,536	$113.50M	35.2%	-30.9%	6.111%
2/15/2023	Nantahala Capital Management LLC	158,033	$5.18M	0.3%	+35.5%	0.279%
2/15/2023	Jefferies Financial Group Inc.	470,026	$15.41M	0.1%	N/A	0.830%
2/14/2023	Point72 Asset Management L.P.	379,300	$12.44M	0.0%	N/A	0.670%
2/14/2023	Price T Rowe Associates Inc. MD	1,805,574	$59.21M	0.0%	+163.5%	3.188%
2/14/2023	Two Sigma Investments LP	76,169	$2.50M	0.0%	-16.7%	0.134%
2/14/2023	Driehaus Capital Management LLC	1,012,320	$33.19M	0.5%	+0.3%	1.787%
2/13/2023	Charles Schwab Investment Management Inc.	199,773	$6.55M	0.0%	+24.5%	0.353%
2/13/2023	Deutsche Bank AG	13,081	$0.43M	0.0%	+31.3%	0.023%
2/13/2023	Callan Capital LLC	19,180	$0.63M	0.1%	N/A	0.034%
2/13/2023	Vivo Capital LLC	1,303,294	$42.74M	4.9%	-3.9%	2.301%
2/13/2023	Wells Fargo & Company MN	2,015	$66K	0.0%	-52.0%	0.004%
2/13/2023	Barclays PLC	10,835	$0.36M	0.0%	+255.5%	0.019%
2/13/2023	Renaissance Technologies LLC	6,800	$0.22M	0.0%	+17.2%	0.012%
2/13/2023	The Manufacturers Life Insurance Company	41,080	$1.35M	0.0%	+46.9%	0.073%
2/13/2023	Credit Suisse AG	12,866	$0.42M	0.0%	+10,030.7%	0.023%
2/13/2023	Geode Capital Management LLC	509,414	$16.70M	0.0%	+24.6%	0.899%
2/13/2023	American Century Companies Inc.	296,088	$9.71M	0.0%	-0.7%	0.523%
2/13/2023	Advisory Research Inc.	33,600	$1.10M	0.1%	+5.9%	0.059%
2/13/2023	JPMorgan Chase & Co.	16,953	$0.56M	0.0%	+38.4%	0.030%
2/10/2023	Bank of America Corp DE	53,730	$1.76M	0.0%	+399.1%	0.095%
2/10/2023	American International Group Inc.	11,795	$0.39M	0.0%	+10.8%	0.021%
2/10/2023	Amalgamated Bank	4,207	$0.14M	0.0%	+17.0%	0.007%
2/10/2023	Sei Investments Co.	16,066	$0.53M	0.0%	+38.3%	0.028%
2/10/2023	Freemont Management S.A.	7,107	$0.23M	0.0%	N/A	0.013%
2/10/2023	Cheyne Capital Management UK LLP	20,035	$0.66M	1.1%	N/A	0.035%
2/10/2023	Lord Abbett & CO. LLC	1,843,407	$60.45M	0.2%	+6.1%	3.255%
2/10/2023	Moors & Cabot Inc.	6,600	$0.22M	0.0%	+10.0%	0.012%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	12,843	$0.42M	0.0%	+12.6%	0.023%
2/9/2023	Principal Financial Group Inc.	11,583	$0.38M	0.0%	N/A	0.020%
2/9/2023	Citigroup Inc.	4,917	$0.16M	0.0%	+104.2%	0.009%
2/8/2023	UBS Group AG	1,229	$40K	0.0%	N/A	0.002%
2/8/2023	Swiss National Bank	40,900	$1.34M	0.0%	N/A	0.072%
2/8/2023	Russell Investments Group Ltd.	72,533	$2.38M	0.0%	N/A	0.128%
2/7/2023	TD Asset Management Inc	30,836	$1.01M	0.0%	+89.9%	0.054%
2/3/2023	Birchview Capital LP	22,000	$0.72M	0.5%	-51.1%	0.039%
2/2/2023	SG Americas Securities LLC	7,975	$0.26M	0.0%	+110.8%	0.014%
2/2/2023	ProShare Advisors LLC	7,893	$0.26M	0.0%	N/A	0.014%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	2,032	$67K	0.0%	N/A	0.004%
2/1/2023	Janney Montgomery Scott LLC	12,957	$0.43M	0.0%	-38.0%	0.023%
1/30/2023	New York State Common Retirement Fund	15,465	$0.51M	0.0%	-21.7%	0.027%
1/25/2023	Connective Portfolio Management LLC	15,000	$0.49M	1.0%	N/A	0.026%
1/24/2023	Moody Aldrich Partners LLC	79,250	$2.60M	0.5%	N/A	0.140%
1/24/2023	Carnegie Capital Asset Management LLC	15,708	$0.52M	0.0%	N/A	0.028%
1/20/2023	Avestar Capital LLC	6,469	$0.21M	0.0%	N/A	0.011%
12/8/2022	Bank of New York Mellon Corp	80,445	$2.81M	0.0%	+60.0%	0.142%
11/28/2022	Birchview Capital LP	45,000	$1.57M	1.1%	+36.4%	0.079%
11/21/2022	California State Teachers Retirement System	8,852	$0.31M	0.0%	-7.6%	0.016%
11/16/2022	Advisory Research Inc.	31,726	$1.11M	0.1%	N/A	0.056%
11/16/2022	Fred Alger Management LLC	11,879	$0.42M	0.0%	N/A	0.021%
11/16/2022	Maven Securities LTD	150,000	$5.24M	0.1%	N/A	0.265%
11/15/2022	Alliancebernstein L.P.	15,200	$0.53M	0.0%	N/A	0.027%
11/15/2022	State Street Corp	440,943	$15.39M	0.0%	+35.5%	0.779%
11/15/2022	Two Sigma Advisers LP	8,000	$0.28M	0.0%	N/A	0.014%
11/15/2022	Two Sigma Investments LP	91,395	$3.19M	0.0%	N/A	0.161%
11/15/2022	Tri Locum Partners LP	125,000	$4.36M	1.2%	N/A	0.221%
11/15/2022	Vanguard Group Inc.	1,103,953	$38.54M	0.0%	+21.7%	1.949%
11/15/2022	Price T Rowe Associates Inc. MD	685,342	$23.93M	0.0%	N/A	1.210%
11/15/2022	Lord Abbett & CO. LLC	1,737,778	$60.67M	0.2%	N/A	3.068%
11/15/2022	Logos Global Management LP	1,397,680	$48.79M	6.0%	-39.6%	2.468%
11/15/2022	EcoR1 Capital LLC	400,000	$13.96M	0.4%	-69.2%	0.706%
11/15/2022	Farallon Capital Management LLC	70,000	$2.44M	0.0%	-92.5%	0.124%
11/15/2022	Bank of New York Mellon Corp	80,445	$2.81M	0.0%	+60.0%	0.142%
11/15/2022	BlackRock Inc.	1,381,503	$48.23M	0.0%	+30.7%	2.439%
11/15/2022	Boxer Capital LLC	850,000	$29.67M	1.7%	N/A	1.501%
11/15/2022	Caas Capital Management LP	60,000	$2.03M	0.1%	N/A	0.106%
11/14/2022	Royal Bank of Canada	5,622	$0.20M	0.0%	+4,326.8%	0.010%
11/14/2022	Tudor Investment Corp Et Al	22,400	$0.78M	0.0%	-37.1%	0.040%
11/14/2022	Vivo Capital LLC	1,355,861	$47.33M	5.2%	-29.4%	2.394%
11/14/2022	Cubist Systematic Strategies LLC	24,089	$0.84M	0.0%	N/A	0.043%
11/14/2022	Darwin Global Management Ltd.	1,401,123	$48.91M	73.7%	N/A	2.474%
11/14/2022	Renaissance Technologies LLC	5,800	$0.20M	0.0%	N/A	0.010%
11/14/2022	Nuveen Asset Management LLC	69,051	$2.41M	0.0%	-0.6%	0.122%
11/14/2022	VR Adviser LLC	207,925	$7.26M	1.1%	N/A	0.367%
11/14/2022	Integral Health Asset Management LLC	100,000	$3.49M	0.7%	N/A	0.177%
11/14/2022	UBS Oconnor LLC	29,400	$1.03M	0.0%	N/A	0.052%
11/14/2022	Pictet Asset Management SA	1,071,983	$37.42M	0.1%	N/A	1.893%
11/14/2022	Maven Securities LTD	150,000	$5.24M	0.1%	N/A	0.265%
11/10/2022	Nantahala Capital Management LLC	116,633	$4.07M	0.3%	N/A	0.206%
11/10/2022	ExodusPoint Capital Management LP	11,867	$0.41M	0.0%	N/A	0.021%
11/8/2022	Qiming U.S. Ventures Management LLC	746,370	$26.06M	37.8%	-18.0%	1.320%
11/8/2022	New York State Common Retirement Fund	19,752	$0.69M	0.0%	+61.3%	0.035%
11/8/2022	Moors & Cabot Inc.	6,000	$0.21M	0.0%	N/A	0.011%
11/7/2022	Birchview Capital LP	45,000	$1.57M	1.1%	+36.4%	0.080%
11/7/2022	TD Asset Management Inc.	16,240	$0.57M	0.0%	N/A	0.029%
11/3/2022	The Manufacturers Life Insurance Company	27,960	$0.98M	0.0%	N/A	0.049%
11/3/2022	Barclays PLC	3,048	$0.11M	0.0%	-98.9%	0.005%

Data available starting January 2016

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company is developing VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.

Today's Range

Now: $37.75

$37.73

$39.56

50 Day Range

MA: $40.49

$33.65

$46.65

52 Week Range

Now: $37.75

$10.15

$47.25

Volume

1,113,909 shs

Average Volume

759,413 shs

Market Capitalization

$2.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Ventyx Biosciences?: Ventyx Biosciences' top insider investors include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
Christopher W Krueger (Insider)
John Nuss (Insider)
Martin Auster (CFO)
Global Strategic Fund I Venbio (Major Shareholder)
William Richard White (Director)
Learn More about top insider investors at Ventyx Biosciences.
Who are the major institutional investors of Ventyx Biosciences?: Ventyx Biosciences' top institutional investors include:
venBio Partners LLC — 6.11%
Lord Abbett & CO. LLC — 3.25%
Price T Rowe Associates Inc. MD — 3.19%
Vivo Capital LLC — 2.30%
Avidity Partners Management LP — 2.27%
Driehaus Capital Management LLC — 1.79%
Learn More about top institutional investors of Ventyx Biosciences stock.
Which institutional investors are selling Ventyx Biosciences stock?: Within the last quarter, VTYX stock was sold by these institutional investors:
venBio Partners LLC
Vivo Capital LLC
Susquehanna International Group LLP
EAM Global Investors LLC
Birchview Capital LP
EAM Investors LLC
Two Sigma Investments LP
Janney Montgomery Scott LLC
Within the last year, company insiders that have sold Ventyx Biosciences company stock include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
Christopher W Krueger (Insider)
John Nuss (Insider)
Martin Auster (CFO)
Global Strategic Fund I Venbio (Major Shareholder)
Learn More investors selling Ventyx Biosciences stock.
Which institutional investors are buying Ventyx Biosciences stock?: During the last quarter, VTYX stock was acquired by institutional investors including:
Avidity Partners Management LP
Price T Rowe Associates Inc. MD
Jefferies Financial Group Inc.
Point72 Asset Management L.P.
Lord Abbett & CO. LLC
Geode Capital Management LLC
Millennium Management LLC
Moody Aldrich Partners LLC

Could This Be The Biggest Stock Of 2023?